Search Results - "ZIER, Karen"

Refine Results
  1. 1

    Supportive Programs Increase Medical Students' Research Interest and Productivity by Zier, Karen, Friedman, Erica, Smith, Lawrence

    Published in Journal of investigative medicine (01-05-2006)
    “…BackgroundAdvances in biomedical research during the last decade have highlighted the necessity of attracting greater numbers of physicians to careers that…”
    Get full text
    Journal Article
  2. 2

    Publications by Students Doing a Year of Full-Time Research: What Are Realistic Expectations? by Cohen, Benjamin L., MD, Friedman, Erica, MD, Zier, Karen, PhD

    Published in The American journal of medicine (01-06-2008)
    “…Clinical Research Training Program at the National Institutes for Health and Doris Duke Clinical Research Fellowship was created to provide medical and dental…”
    Get full text
    Journal Article
  3. 3

    Goals of medical students participating in scholarly concentration programmes by Alberson, Kurt, Arora, Vineet M, Zier, Karen, Wolfson, Rachel K

    Published in Medical education (01-08-2017)
    “…Objectives Scholarly concentration (SC) programmes are increasingly common in medical school curricula, fostering student participation in mentored research…”
    Get full text
    Journal Article
  4. 4

    An innovative portfolio of research training programs for medical students by Zier, Karen, Wyatt, Christina, Muller, David

    Published in Immunologic research (01-12-2012)
    “…Medical student education continues to evolve, with an increasing emphasis on evidence-based decision making in clinical settings. Many schools are introducing…”
    Get full text
    Journal Article
  5. 5

    Surrogate Markers of Antitumor Responses: In Vitro Activation of T Cells by Autologous Tumor Peptides by ZIER, Karen, MADDUX, Jean-Marie, JOHNSON, Kristen, SUNG, Max, MANDELI, John, EISENBACH, Lea, SCHWARTZ, Myron

    Published in Clinical cancer research (01-03-2001)
    “…The increasing ability to augment antitumor immunity in model systems has led to increased numbers of clinical trials. However, progress in detecting immune…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Resection of Solid Tumors Reverses T Cell Defects and Restores Protective Immunity by Salvadori, Silvia, Martinelli, Giorgio, Zier, Karen

    Published in The Journal of immunology (1950) (15-02-2000)
    “…We have previously reported that CTL were demonstrable early after inoculation of CMS5 fibrosarcoma cells, but that they disappeared within 3 wk. These mice…”
    Get full text
    Journal Article
  7. 7

    Human tumor vaccines and genetic engineering of tumors with cytokine and histocompatibility genes to enhance immunogenicity by Rosenthal, Felicia M, Zier, Karen S, Gansbacher, Bernd

    Published in Current opinion in oncology (01-11-1994)
    “…Genetically engineered tumor cells can be used as vaccines in order to stimulate an immune response. To date, tumor cells have been modified in vitro so that…”
    Get full text
    Journal Article
  8. 8

    A Multifaceted Program To Encourage Medical Students' Research by Zier, Karen, Stagnaro-Green, Alex

    Published in Academic medicine (01-07-2001)
    “…Describes the successful encouragement of student research provided by the Office of Student Research Opportunities (OSRO) at Mount Sinai School of Medicine…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity by GANSBACHER, B, BANNERJI, R, DANIELS, B, ZIER, K, CRONIN, K, GILBOA, E

    Published in Cancer research (Chicago, Ill.) (15-12-1990)
    “…Retroviral vectors were used to introduce the gamma-interferon (IFN-gamma) gene into CMS-5 cells, a weakly immunogenic tumor of BALB/c origin. After selection…”
    Get full text
    Journal Article
  11. 11

    Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity by GANSBACHER, B, ZIER, K, DANIELS, B, CRONIN, K, RAJAT BANNERJI, ELI GILBOA

    Published in The Journal of experimental medicine (01-10-1990)
    “…To study the effects of localized secretion of cytokines on tumor progression, the gene for human interleukin 2 (IL-2) was introduced via retroviral vectors…”
    Get full text
    Journal Article
  12. 12

    Introducing INSPIRE, a scholarly component in Undergraduate Medical education by Zier, Karen, Coplit, Lisa D.

    Published in The Mount Sinai journal of medicine (01-08-2009)
    “…Individualized learning is a fundamental tenet of the Carnegie Foundation's new recommendations for physician training. A primary goal of Mount Sinai School of…”
    Get full text
    Journal Article
  13. 13

    Launching a New Fellowship for Medical Students: The First Years of the Doris Duke Clinical Research Fellowship Program by Gallin, Elaine K., Le Blancq, Sylvie M.

    Published in Journal of investigative medicine (01-03-2005)
    “…As part of its commitment to increasing the pipeline of physicians pursuing careers in clinical research, the Doris Duke Charitable Foundation launched the…”
    Get full text
    Journal Article
  14. 14

    Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2-secreting tumors by Salvadori, S, Gansbacher, B, Pizzimenti, AM, Zier, KS

    Published in The Journal of immunology (1950) (01-12-1994)
    “…There is considerable evidence to demonstrate that immune function is abnormal in tumor-bearing mice, perhaps accounting, at least in part, for progressive…”
    Get full text
    Journal Article
  15. 15

    Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2 by Salvadori, S, Zier, K

    Published in The Journal of immunology (1950) (15-04-1996)
    “…Previously we reported that T cells from mice bearing parental tumors have a variety of functional and biochemical defects when compared with T cells from mice…”
    Get full text
    Journal Article
  16. 16

    T-cell responses to multiple antigens presented by RNA-transfected APCs: a possible immunomonitoring tool by BARTIDO, Shirley M, ZIER, Karen

    Published in Cancer Immunology, Immunotherapy (01-02-2004)
    “…The increasingly deeper understanding of how the immune system recognizes and destroys tumors promises to enable the development of new approaches for gene…”
    Get full text
    Journal Article
  17. 17

    Cell Mediated Immunity: Separation of Cells Involved in Recognitive and Destructive Phases by Bach, Fritz H., Segall, Miriam, Zier, Karen Stouber, Sondel, Paul M., Alter, Barbara J., Bach, Marilyn L.

    “…The mixed leukocyte culture (MLC) and the cell mediated lympholysis (CML) assays are used as in vitro models of the afferent, or recognitive, and efferent, or…”
    Get full text
    Journal Article
  18. 18

    B7-1 amplifies the response to interleukin-2-secreting tumor vaccines in vivo, but fails to induce a response by naive cells in vitro by Salvadori, S, Gansbacher, B, Wernick, I, Tirelli, S, Zier, K

    Published in Human gene therapy (01-10-1995)
    “…Parental and interleukin-2 (IL-2)-secreting CMS5 tumor cells were transfected with the B7-1 costimulatory molecule to amplify anti-tumor responses. CMS5 cells…”
    Get more information
    Journal Article
  19. 19

    The impact of gene therapy on T cell function in cancer by Zier, K S, Gansbacher, B

    Published in Human gene therapy (01-10-1995)
    “…Studies of signal transduction by T cells are slowly identifying the intracellular messengers that must be generated for full T cell activation to take place…”
    Get more information
    Journal Article
  20. 20

    IFNγ secretion following stimulation with total tumor peptides from autologous human tumors by Zier, Karen, Johnson, Kristen, Maddux, Jean-Marie, Sung, Max, Mandeli, John, Eisenbach, Lea, Schwartz, Myron

    Published in Journal of immunological methods (31-07-2000)
    “…Several issues remain to be resolved before the efficacy of various approaches to elicit anti-tumor immunity in patients can be evaluated. First, in vitro…”
    Get full text
    Journal Article